Stefan H. E. Kaufmann


Stefan Hugo Ernst Kaufmann is a German immunologist and microbiologist and is one of the highly cited immunologists worldwide for the decade 1990 to 2000.. He is amongst the 0.01% most cited scientists of ca. 7 million scientists in 22 major scientific fields globally.

Biography

Kaufmann is a German immunologist and microbiologist with focus on infection biology. He received his Dr. Rer. Nat. at the University of Mainz in 1977 and his Habilitation in Immunology and Microbiology at the Free University Berlin in 1981. He was Professor at the University of Ulm from 1987 to 1998. Currently, he is Director of the Department of Immunology at the Max Planck Institute for Infection Biology in Berlin, for which he served as Founding Director in 1993. Since 2019 he is Director Emeritus at this institute. Member of the Max Planck Society since 1993. Since 1998 he is also Professor for Immunology and Microbiology at the Charité Berlin. Since 2018 he is Faculty Fellow of the Hagler Institute for Advanced Study at Texas A&M University .
Kaufmann collects historical medicinal books.

Career

Kaufmann has published more than 900 scientific original papers and review articles and according to the Institute for Scientific Information, he is one of the highly cited immunologists with more than 70,000 citations worldwide for the decade 1990 to 2000. His current scientific interest is focussed on the analysis of cell-mediated immunity against intracellular bacteria, the rational design and development of a better vaccine against tuberculosis as well as of biomarkers for reliable diagnosis of TB disease. Biomarker discovery is done in a multicentric approach with seven partner institutes in Africa with support from the Bill and Melinda Gates Foundation . His vaccine against tuberculosis is currently in phase III clinical trial assessment. A phase III vaccine trial to test prevention of tuberculosis recurrence and a phase III trial to test prevention of tuberculosis disease in household contacts of tuberculosis patients are ongoing in India. Moreover, for a clinical study assessing therapy of bladder cancer with the vaccine has revealed highly promising data. Furthermore, Kaufmann is actively involved in public awareness of immunology and infectious diseases. He is Past President and Honorary Member of the German Society of Immunology , Past President of the European Federation of Immunological Societies , and Past President of the International Union of Immunological Societies . From 2010 to 2013 he was Member of the Board of the Global Alliance for Vaccines and Immunization as alternate representative of scientific and technical institutes. From 2009 to 2014 he was Member of the Advisory Board of Global Alliance for TB Drug Development , New York. Since 2014 he is member of the Strategic Advisory Committee of the European and Developing Countries Clinical Trials Partnership . Kaufmann is member of the Board of Directors and of the Scientific Advisory Council of the Robert Koch Foundation , which annually awards the Robert Koch Prize and the Robert Koch Medal in gold. Since 2014 he is Chairman of the Board of Trustees of the Schering Foundation .From 2013 to 2014 he was corresponding member of the Board of Trustees and since 2014 he is full member of the Board of Trustees for the Lindau Nobel Laureate meetings for the Lindau Nobel Laureate Meetings .
Kaufmann headed a team that developed a method of using defensis to combat anthrax.

Other activities

Kaufmann has received numerous rewards and honours for his scientific achievements in immunology of infectious diseases including:
In 2007, Kaufmann was conferred the title of Doctor Honoris Causa by the Université de la Mediterranée, Aix-Marseille II, France. In 2014 he received the Gardner Middlebrook Award. Fellow of the Royal College of Physicians of Edinburgh. He is Guest Professor, Tongji University, School of Medicine, Shanghai, China, Honorary Professor, Universidad Peruana Cayetano Heredia, Lima, Peru, and Visiting Professor, Peking Union Medical College, Beijing, China.

Partial bibliography

Latest Thinking:
Latest Thinking: